StockData
COSCIENS Biopharma Inc. logo

COSCIENS Biopharma Inc. (CSCIF) shareholders

CSCIFOTCPerfumes, Cosmetics & Other Toilet PreparationsFiscal year ends December 31
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Mar 31, 2026Last filing: 20-F on Mar 25, 2026Score 1/30
$6.49+0.00 (0.00%)

Close on Oct 19, 2026Market cap $24.10MP/E –Yield –

Ownership

Institutional holdings as of Dec 31, 2025, from 13F filings

Held by institutions
0.0%
0M of 3M shares
Institutional holders
0
0 new, 2 sold out
Net institutional buying
-0M
In Q4 2025
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Goodwood Fund
Joint filing with Goodwood Inc. (8.20%), Peter Puccetti (8.20%) and 1 more
257,2578.20%13D (active) amendmentDec 19, 2024
Peter Puccetti
Joint filing with Goodwood Fund (8.20%), Goodwood Inc. (8.20%) and 1 more
257,2578.20%13D (active) amendmentMay 30, 2025

Top institutional holders

13F holdings as of Sep 30, 2025

HolderShares% of CSCIFValueChange% of portfolio
TD Waterhouse Canada Inc.3,8600.12%$10.15K–0.00%
Osaic Holdings, Inc.500.00%$153–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q4 202500M0.0%0 / 00 / 20M0M
Q3 202520M0.1%0 / 00 / 130M0M
Q2 2025150M1.0%1 / 43 / 10M0M
Q1 2025150M0.9%2 / 24 / 20M0M
Q4 2024150M0.7%8 / 21 / 10M0M
Q3 202490M0.5%9 / 00 / 00M0M

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
–
0M shares short
Days to cover
4.3
At 0M shares a day
Change since last report
-21.3%
From 0M shares
Short volume, 0 days
–
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of COSCIENS Biopharma's stock actually held short. Settlement fails (shares not delivered on time) peaked at 273 shares on Oct 14, 2026 over the last 90 days.

Congress trades

2 trades in COSCIENS Biopharma reported by 1 member of the House

MemberTypeTradedAmountFiled
Roger W. Marshall
KS01 · child
SoldJul 20, 2017$1K–15KAug 6, 2018
382 days late
Roger W. Marshall
KS01 · child
BoughtJul 19, 2017$1K–15KAug 6, 2018
383 days late

See a number that looks wrong?